Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 28
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05496426 | A Study of KL130008 in Adults With Severe Alopecia Areata | ||
| NCT06736327 | A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects with Advanced Solid Tumors | ||
| NCT05265091 | A Study of KL590586 in Patients With Advanced Solid Tumors | ||
| NCT06428331 | A Study of SKB518 in Patients With Advanced Solid Tumors | ||
| NCT03848286 | KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma | ||
| NCT05631262 | SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors | ||
| NCT06674694 | The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia. | ||
| NCT06448312 | A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | ||
| NCT05549804 | A Study of Intratumoral KL340399 in Patients with Advanced Solid Tumors | ||
| NCT06726369 | A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors | ||
| NCT05294172 | KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma | ||
| NCT06670196 | A Study of SKB264 in Combination with Osimertinib Versus Osimertinib in Patients with Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT05347134 | SKB264 Injection Vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer | ||
| NCT05870319 | A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients | ||
| NCT04835142 | Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC | ||
| NCT05367635 | A Study of SKB315 in Patients With Advanced Solid Tumors | ||
| NCT06081959 | Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer | ||
| NCT06279364 | A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer | ||
| NCT05445908 | SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer | ||
| NCT05906537 | SKB410 for Injection in Solid Tumors | ||
| NCT06725381 | A Phase 1 Study of SKB571 in Subjects with Advanced Solid Tumors | ||
| NCT03580564 | An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma | ||
| NCT06711900 | A Study of SKB264 in Combination with Pembrolizumab Versus Chemotherapy in Combination with Pembrolizumab As First-Line Treatment for PD-L1 Negative Patients with Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT05351788 | SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer. | ||
| NCT05387928 | A Study of KL340399 in Patients With Advanced Solid Tumors | ||
| NCT03426371 | Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial | ||
| NCT03017807 | Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer | ||
| NCT05311397 | A Study of A166 in Patients With Advanced Solid Malignant Tumors |
